Ticker: MRCY

Mercury Systems

Aerospace / Defense Industrials Aerospace & Defense
Price 78.19
Reco Sell Potential 31 Risk 74 Updated 2026-11-19

Forecast impact

neutral
Target +36.8% target fill 73.1%
Reaction D5 -2.37% · D10 -3.43%
Impact Potential 0 · Risk 0 valid until 2026-11-22

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Mercury Systems is a technology company specializing in advanced electronics and software solutions for the aerospace and defense sectors. Its core products include secure processing systems, sensor processing, and data analytics solutions. Major business segments encompass avionics, electronic warfare, and radar systems, with primary revenue sources derived from government contracts and defense-related projects.

Investment Profile

The investment profile of Mercury Systems is more aligned with balanced investors, given its focus on stable government contracts and potential for growth in defense technology. The stock may appeal to those looking for moderate risk with opportunities for capital appreciation over time.

Fundamental metrics (experimental) Updated: 2026-11-19
EPS (TTM) — earnings per share for the last 12 months, $
-0.07
Revenue QoQ — quarter-over-quarter revenue growth
-12.6%
EPS surprise
74.7%
20d volatility
5.4%
last ex-date
2015-03-13
AI recommendation changes
Date Before After Reason
2026-10-13 Hold Sell Weak fundamentals and negative momentum raise significant concerns.
2026-10-05 Sell Hold Weak fundamentals and high risk limit upside potential.
2026-08-27 Hold Sell Weak fundamentals and negative momentum raise significant risk.
Analyst forecasts
Date Analyst Action Target Price Then
2026-10-23 Piper Sandler Target Lowered 131 → 107 75.56
2026-09-14 Guggenheim Update — → 115 81.03
2026-08-20 Truist Financial Target Raised 109 → 120 99
News Page 1 of 1
Mercury Systems Nvidia Unilever Teradyne CoreWeave Republic Services Zebra Technologies Corning Apple

Analysts Baird downgraded Nvidia (NVDA) to neutral amid negative catalysts, while UBS reiterated Apple (AAPL) as neutral and Deutsche Bank upgraded Unilever (UL) to buy

Recent analyst calls indicate a mixed outlook for major tech and healthcare companies, with Nvidia facing downgrades due to supply and demand concerns, while others like CoreWeave and Unilever receive upgrades based on growth potential and market positioning.
Mercury Systems La-Z-Boy Estee Lauder Lowe's Companies Analog Devices Toll Brothers Keysight Technologies Merck Moderna

Stocks to Watch: Moderna and Merck Surge on Positive Cancer Vaccine Trial Results, While Lowe’s and La-Z-Boy Face Declines

Moderna and Merck's shares surged following positive results from a late-stage trial of their personalized cancer vaccine, while other companies like Keysight Technologies and Estee Lauder reported strong earnings, impacting their stock prices positively. Conversely, Lowe's and La-Z-Boy faced declines due to disappointing forecasts and earnings results.